News from our Industry Partner - Bayer
News from our Industry Partner - Bayer

Bayer UK recognises that this is a critical time for everyone. We would like to reassure you that we are making every effort to support healthcare professionals, the NHS and patients through digital routes.

Guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with Type 2 diabetes and atherosclerotic cardiovascular disease (coronary artery disease, peripheral arterial disease, cerebrovascular disease)
Guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with Type 2 diabetes and atherosclerotic cardiovascular disease (coronary artery disease, peripheral arterial disease, cerebrovascular disease)

It will be self-evident to any cardiologist that many of our patients also suffer from diabetes and its complications. In the past care has tended to be silo specific with many cardiologists not paying a great deal of attention to the management of diabetes but this is changing with the development of drugs for diabetes that directly impact on cardiovascular outcomes. 

June 2020

PCCS and Thrombosis UK webinar: How should General Practice consider respiratory issues in a time of COVID-19?

Tuesday, 7th July 2020
19:30 – 20:30 

Registration FOC: here

1 CPD credit awarded.

Hosted and supported by Primary Care Cardiovascular Society & Thrombosis UK, the webinar is open to all healthcare and allied professionals but will be of particular interest to those working in General Practice and the community, including care homes, and managing patients with a diagnosis or suspected history of COVID-19.

Committee Announcement 10th June 2020

We are delighted to announce that we have a new member of the PCCS Commitee: Trudie Lobban MBE, FRCP Edin

May 2020

Important Read - Network based care for Heart Valve Disease

Please click here to download the service framework for the care of patients with heart valve disease.

Safe switching of warfarin to DOACs

The PCCS, alongside a number of other societies and associations across the UK, has come together to provide guidance on the safe switching of warfarin to DOACs.

April 2020

Committee Announcement April 2020

We are delighted to announce that Dr Matt Fay has agreed to join the PCCS Committee forthwith. Matt will be a great addition to the team and it’s a privilege to have a major figure in national primary care cardiology joining us.

Recognising Heart Attacks, Strokes and Heart Failure during the Coronavirus pandemic and beyond

We are hearing that fewer people are being seen in hospital with heart attacks, strokes and heart failure in recent weeks, which suggests that people are not seeking help when they should do.

British Heart Valve Society - COVID-19 Statement

Please follow the following link to see a position statement from the British Heart Valve Society regarding heart valve disease during the Coronavirus pandemic:

https://www.bhvs.org.uk/covid-19-coronavirus-illness-and-heart-valve-disease/

Treatment of patients with ACEi or ARB in relation to COVID-19

The British Cardiovascular Society (BCS) together with the British Society for Heart Failure (BSH) have released the following joint statement

March 2020

Announcing the all new, highly interactive conference for primary care

Issues & Answers in Primary Care Today – CVplus: Because CVD is never alone 20-21 November 2020, Jurys Inn Hinckley Island Hotel & Conference Venue

British Heart Valve Society (BHVS) - Clinic Study Day

BHVS Valve Clinic Study Day - 23rd June 2020 
Crowne Plaza, Birmingham 

February 2020

BSH Heart Failure Nurse and Healthcare Professionals Education Day - Friday 27th March 2020

British Society for Heart Failure's 10th Annual Heart Failure Nurse and Healthcare Professionals Education Day 

January 2020

EPCCS - Annual Cardiovascular Summit for Primary Care - 2020

Professor Ahmet Fuat will be presenting at the European Primary Care Cardiovascular Society - Annual Cardiovascular Summit for Primary Care on March 19th - 20th - Prague, Czech Republic 

https://ipccs.org/2019/07/23/epccs-summit-2020/

July 2019

Committee Announcement 20th June 2019

We are delighted to announce that we have two new members of the PCCS Committee: Dr Paul Ferenc GP and GPSI in Cardiology. Graduated from Birmingham and completed foundation years in the North West, where he undertook a cardiology house job until moving to Worcestershire to undertake GP training. Since 2015 Dr Ferenc has been working at the local hospital as a GPwSI in cardiology with the local cardiology team.

June 2019

2nd PCCS Annual Conference – Guidelines into Practice 2019

 

The PCCS 2nd Annual Conference ‘Cardiovascular Guidelines into Practice’ took place on Thursday 16th May at the Hallam Conference Centre in Central London. A 70 strong multidisciplinary attendance of GPs, nurses, pharmacists and other health care professionals involved in cardiovascular disease care from across the UK were treated to a day of high quality and entertaining education.

The meeting was opened by our President Professor Ahmet Fuat who outlined the program, reiterated the aims of the PCCS and informed us of PCCS Board changes to take place formally at our AGM at the PCCJ meeting in Nottingham in November. Professor Ahmet Fuat, Dr Kathryn Griffith (Secretary) and Professor Michael Norton (Treasurer) will stand down to allow President-Elect Dr Jim Moore, Secretary-Elect Helen Williams and Treasurer-Elect Dr Richard Blakey to take over. Professor Fuat with stay on as immediate Past President, Professor Norton as an observer member
with a remit in Resuscitation Medicine and Dr Griffith will stand down completely. Two new board members will be elected and announced soon. Prof Fuat extended a deep debt of gratitude to both colleagues and in particular Kathryn who has put so much into the Society over many years. Thank you Kathryn.

The meeting was opened by Dr Matt Kearney NHSE National Clinical Director for CVD Prevention. His main message was that primary care needs to work differently using pharmacists, nurses and others to increase detection and management of hypertension, atrial fibrillation, lipids, familial hypercholesterolaemia and heart failure. This he said was imperative to address the recent National picture of a slowing down of CVD mortality and morbidity and close the detection and treatment gap in the priority areas outlined above. He felt the PCCS were central to CVD Leadership and implementation
of the proposed CVD Prevention Program and emerging Primary Care Networks
(PCNs) which will be expected to deliver to drive up CVD care standards.

There followed six sessions addressing diagnosis and management of patients presenting with common primary care symptoms and signs including palpitations, breathlessness, raised blood pressure, coronary artery disease with residual CV risk, diabetic patient with high CVD risk and a patient with a raised cholesterol. Real life case studies were outlined by session chairs, followed by presentations on diagnostic work up, guidelines and practical examples from around the country of how guidelines had been put into practice. All sessions were expertly presented and generated considerable
debate amongst our lively and interactive audience.

We would like to thank all of the speakers that contributed to the day and in particular the following:

Primary Care Cardiovascular Journal
British Society for Heart Failure
The British and Irish Hypertension Society
The British Cardiac Society
The Primary Care Diabetes Society
British Heart Foundation
AHSN North East

Finally we wouldn’t have been able to run such a fantastic day if it hadn’t been for our industry sponsors

Bayer
Novartis
Amgen
Medtronic
Sanofi

Please watch this space for further opportunities to download the slides.

March 2019

Updated NICE Heart Failure guidelines - furthering evidence or a missed opportunity

Please come and see us at this year's PCCJ conference - Issues & Answers in Cardiovascular Disease, 16th-17th November 2018, East Midlands Conference Centre, Nottingham.

Our stand will be in the main hall, plus our session this year is: Updated NICE Heart Failure guidelines - furthering evidence or a missed opportunity 17.30-18.40, Conference Suite 1. This will be immediately followed by our AGM from 18.40 - 19.15. We look forward to seeing you there.

June 2017

April 2017

October 2016

Education and networking
Education and networking

July 2016

May 2016

January 2016

Secretariat services provided by:
LCW Consulting Ltd
 Suite 1, Daley House, 7 Bridge Road Business Park, Bridge Road, Haywards Heath, West Sussex RH16 1TX 
E: admin@lcwconsulting.co.uk T: 01444 414264